Showing results (561-570 of 591) with videos related to
Sort By:
Pageof 60
Cancer Immunity|January 8, 2010
Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapyJianda Yuan, David B Page, Geoffrey Y Ku, et al.Cancer Immunity|April 20, 2007
T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 proteinAkiko Uenaka, Hisashi Wada, Midori Isobe, et al.Proceedings of the National Academy of Sciences of the United States of America|September 22, 2011
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumabJianda Yuan, Matthew Adamow, Brian A Ginsberg, et al.Proceedings of the National Academy of Sciences of the United States of America|January 21, 1997
The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamilyJ K Heath, S J White, C N Johnstone, et al.International Journal of Cancer|March 18, 2011
Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccinationJunji Kawada, Hisashi Wada, Midori Isobe, et al.Proceedings of the National Academy of Sciences of the United States of America|May 23, 2007
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-primingDanila Valmori, Naira E Souleimanian, Valeria Tosello, et al.Proceedings of the National Academy of Sciences of the United States of America|June 16, 2004
Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvantQiyuan Chen, Heather Jackson, Phillip Parente, et al.The Journal of Biological Chemistry|October 11, 1996
Purification and characterization of a novel restricted antigen expressed by normal and transformed human colonic epitheliumB Catimel, G Ritter, S Welt, et al.The Journal of Biological Chemistry|April 13, 2004
Identification of the epitope for the epidermal growth factor receptor-specific monoclonal antibody 806 reveals that it preferentially recognizes an untethered form of the receptorTerrance G Johns, Timothy E Adams, Jennifer R Cochran, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2013
Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG proteinBernardo Sgarbi Reis, Achim A Jungbluth, Denise Frosina, et al.Pageof 60